Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
HZN
|
James F Sistek
Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,122 Reduced 1.93% |
$5,846
$5.21 p/Share
|
Mar 01
2022 |
KLXE
|
Keefer Mc Govern Lehner
Officer |
SELL
Open market or private sale
|
Direct | 3,080 Reduced 4.07% |
$20,790
$6.75 p/Share
|
Mar 01
2022 |
SALM
|
David Evans
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,170 Added 50.0% |
-
|
Mar 01
2022 |
CXDO
|
Steven G Mihaylo |
BUY
Open market or private purchase
|
Direct | 3,000 Added 0.03% |
$13,350
$4.45 p/Share
|
Mar 01
2022 |
GRAMF
|
Dennis O'Malley
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,293 Reduced 0.97% |
$6,139
$1.43 p/Share
|
Mar 01
2022 |
GRAMF
|
Dennis O'Malley
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,656 Added 1.71% |
-
|
Mar 01
2022 |
TRHC
|
Gordon Tunstall |
BUY
Open market or private purchase
|
Direct | 10,000 Added 24.96% |
$55,000
$5.5 p/Share
|
Mar 01
2022 |
SURF
|
Vito J. Palombella
Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct | 38,000 Added 29.3% |
-
|
Mar 01
2022 |
SURF
|
Jessica Fees
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 38,000 Added 24.46% |
-
|
Mar 01
2022 |
SURF
|
Henry C. Rath
Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct | 38,000 Added 50.0% |
-
|
Mar 01
2022 |
SURF
|
Alison Oneill
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 38,000 Added 35.78% |
-
|
Mar 01
2022 |
SURF
|
Robert W. Ross
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 56,000 Added 33.63% |
-
|
Mar 01
2022 |
AIRG
|
James K Sims |
BUY
Open market or private purchase
|
Direct | 5,000 Added 1.6% |
$45,400
$9.08 p/Share
|
Mar 01
2022 |
AIRG
|
Morad Sbahi
Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,003 Added 23.34% |
-
|
Mar 01
2022 |
AIRG
|
Ali Sadri
Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct | 11,671 Added 33.02% |
-
|
Mar 01
2022 |
AIRG
|
Jacob Suen
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 10,897 Reduced 7.58% |
$95,349
$8.75 p/Share
|
Mar 01
2022 |
AIRG
|
Jacob Suen
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 26,144 Added 15.39% |
-
|
Mar 01
2022 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 25 Added 0.01% |
$746
$29.85 p/Share
|
Mar 01
2022 |
AXLA
|
Margaret Koziel
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 553 Reduced 2.03% |
$1,029
$1.86 p/Share
|
Mar 01
2022 |
KLR
|
John J Mikulsky
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.94% |
$76,900
$7.69 p/Share
|
Mar 01
2022 |
KLR
|
Avi S Katz
Director |
SELL
Open market or private sale
|
Direct | 1,157 Reduced 0.09% |
$8,967
$7.75 p/Share
|
Mar 01
2022 |
DRTT
|
Shauna R King
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 50.0% |
$9,500
$1.9 p/Share
|
Mar 01
2022 |
DRTT
|
Jeffrey Calkins
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 19,721 Reduced 13.24% |
$37,075
$1.88 p/Share
|
Mar 01
2022 |
DRTT
|
Jeffrey Calkins
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 25,490 Added 16.4% |
-
|
Mar 01
2022 |
DRTT
|
Jeffrey Calkins
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,925 Added 12.09% |
-
|
Mar 01
2022 |
DRTT
|
Mark Greffen
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 21,364 Reduced 17.61% |
$40,164
$1.88 p/Share
|
Mar 01
2022 |
DRTT
|
Mark Greffen
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 25,490 Added 19.95% |
-
|
Mar 01
2022 |
DRTT
|
Mark Greffen
Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct | 19,016 Added 14.85% |
-
|
Mar 01
2022 |
DRTT
|
Jennifer Warawa
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 46,371 Reduced 24.3% |
$87,177
$1.88 p/Share
|
Mar 01
2022 |
DRTT
|
Jennifer Warawa
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 35,539 Added 24.39% |
-
|
Mar 01
2022 |
DRTT
|
Jennifer Warawa
Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 80,677 Added 31.35% |
-
|
Mar 01
2022 |
DRTT
|
Charles R Kraus
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 21,241 Added 25.45% |
-
|
Mar 01
2022 |
DRTT
|
Charles R Kraus
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 21,591 Added 22.06% |
-
|
Mar 01
2022 |
DRTT
|
Charles R Kraus
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 15,163 Reduced 18.09% |
$28,506
$1.88 p/Share
|
Mar 01
2022 |
DRTT
|
Geoffrey D. Krause
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 25,571 Reduced 15.46% |
$48,073
$1.88 p/Share
|
Mar 01
2022 |
DRTT
|
Geoffrey D. Krause
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 30,800 Added 17.73% |
-
|
Mar 01
2022 |
DRTT
|
Geoffrey D. Krause
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 22,473 Added 12.98% |
-
|
Mar 01
2022 |
FUSN
|
John Valliant
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 847 Reduced 0.2% |
$6,242
$7.37 p/Share
|
Mar 01
2022 |
MLVF
|
James W Barrett
Director |
BUY
Open market or private purchase
|
Direct | 162 Added 1.02% |
$2,647
$16.34 p/Share
|
Mar 01
2022 |
MLVF
|
Julia D Corelli
Director |
BUY
Open market or private purchase
|
Direct | 162 Added 1.62% |
$2,647
$16.34 p/Share
|
Mar 01
2022 |
MLVF
|
Norman Feinstein
Director |
BUY
Open market or private purchase
|
Indirect | 177 Added 1.13% |
$2,892
$16.34 p/Share
|
Mar 01
2022 |
MLVF
|
Andrew D. Fish
Director |
BUY
Open market or private purchase
|
Direct | 177 Added 2.39% |
$2,892
$16.34 p/Share
|
Mar 01
2022 |
MLVF
|
Howard Kent
Director |
BUY
Open market or private purchase
|
Direct | 248 Added 0.15% |
$4,052
$16.34 p/Share
|
Mar 01
2022 |
MLVF
|
Cynthia F Leitzell
Director |
BUY
Open market or private purchase
|
Direct | 193 Added 0.94% |
$3,154
$16.34 p/Share
|
Mar 01
2022 |
MLVF
|
Stephen P Scartozzi
Director |
BUY
Open market or private purchase
|
Direct | 162 Added 1.58% |
$2,647
$16.34 p/Share
|
Mar 01
2022 |
ZY
|
Aaron Kimball
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 3.25% |
$95,250
$3.81 p/Share
|
Mar 01
2022 |
UBFO
|
Michael T Woolf
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 396 Added 0.16% |
-
|
Mar 01
2022 |
UBFO
|
Dennis R Woods
CEO |
BUY
Other acquisition or disposition
|
Indirect | 0 Added 0.0% |
-
|
Mar 01
2022 |
UBFO
|
Dennis R Woods
CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 353 Added 0.04% |
-
|
Mar 01
2022 |
UBFO
|
Dennis R Woods
CEO |
BUY
Other acquisition or disposition
|
Direct | 0 Added 0.0% |
-
|
Mar 01
2022 |